Edward Mena

2.4k total citations
28 papers, 696 citations indexed

About

Edward Mena is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Edward Mena has authored 28 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 18 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Edward Mena's work include Liver Disease Diagnosis and Treatment (17 papers), Liver Diseases and Immunity (10 papers) and Liver Disease and Transplantation (7 papers). Edward Mena is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver Diseases and Immunity (10 papers) and Liver Disease and Transplantation (7 papers). Edward Mena collaborates with scholars based in United States, Germany and France. Edward Mena's co-authors include Mazen Noureddin, Arun J. Sanyal, Tsuyoshi Todo, Shelly C. Lu, Aasim Sheikh, Stephen A. Harrison, Sanjaya K. Satapathy, Abdul Jabbar, Bradley Freilich and Zachary Goodman and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Edward Mena

23 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Mena United States 14 471 364 123 122 97 28 696
Mengfei Liu United States 9 317 0.7× 257 0.7× 131 1.1× 154 1.3× 31 0.3× 22 696
Valérie Bourcier France 14 813 1.7× 875 2.4× 207 1.7× 112 0.9× 61 0.6× 26 1.2k
Fujimasa Tada Japan 12 382 0.8× 263 0.7× 72 0.6× 57 0.5× 59 0.6× 36 564
Ryu Sasaki Japan 12 367 0.8× 430 1.2× 71 0.6× 79 0.6× 26 0.3× 54 616
Bo Wei China 12 350 0.7× 340 0.9× 246 2.0× 177 1.5× 17 0.2× 46 676
Yoshimichi Haruna Japan 14 504 1.1× 648 1.8× 270 2.2× 131 1.1× 66 0.7× 31 928
Zhengrui You China 14 284 0.6× 284 0.8× 130 1.1× 120 1.0× 24 0.2× 24 583
Carmelo Antonio Caserta Italy 10 255 0.5× 129 0.4× 47 0.4× 118 1.0× 90 0.9× 14 574
Kota Tsuruya Japan 13 175 0.4× 206 0.6× 99 0.8× 60 0.5× 40 0.4× 46 408
Víctor Sapena Spain 12 228 0.5× 222 0.6× 74 0.6× 59 0.5× 24 0.2× 35 422

Countries citing papers authored by Edward Mena

Since Specialization
Citations

This map shows the geographic impact of Edward Mena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Mena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Mena more than expected).

Fields of papers citing papers by Edward Mena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Mena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Mena. The network helps show where Edward Mena may publish in the future.

Co-authorship network of co-authors of Edward Mena

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Mena. A scholar is included among the top collaborators of Edward Mena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Mena. Edward Mena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunn, Winston, Ashwani K. Singal, Imad Asaad, et al.. (2025). OS-097 Evaluating noninvasive diagnostic pathways for identifying MASH patients eligible for Resmetirom therapy: a real-world cohort analysis. Journal of Hepatology. 82. S66–S66.
2.
3.
Burton, James R., et al.. (2025). Cholate Clearance: Improving the Assessment of Liver Health Compared to Current Liver Tests. Gastro Hep Advances. 5(2). 100814–100814.
4.
Singal, Ashwani K., Imad Asaad, Edward Mena, et al.. (2025). SAT-438 General characteristics of the patients prescribed Resmetirom: data derived from six tertiary care centers in the United States. Journal of Hepatology. 82. S634–S635.
5.
Levy, Cynthia, Stephen H. Caldwell, Parvez Mantry, et al.. (2024). Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study. Clinical and Translational Gastroenterology. 15(8). e00744–e00744. 1 indexed citations
6.
Noureddin, Mazen, Edward Mena, Raj Vuppalanchi, et al.. (2023). Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology Communications. 7(5). 24 indexed citations
7.
Vuppalanchi, Raj, Stephen H. Caldwell, Nikolaos Pyrsopoulos, et al.. (2021). Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis. Journal of Hepatology. 76(1). 75–85. 50 indexed citations
8.
Lewin, Jörn, Denise Kottwitz, Theo deVos, et al.. (2021). Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study. BMC Gastroenterology. 21(1). 136–136. 31 indexed citations
9.
Wei, Ke, Thao Tran, Patrick Chang, et al.. (2020). MRI Automated T1 Signal Intensity Detection of Diffuse Brain Manganese Accumulation in Cirrhosis. Journal of Neuroimaging. 31(1). 186–191. 1 indexed citations
10.
Palmer, Suzanne L., et al.. (2020). Diagnosis of Focal Nodular Hyperplasia (FNH) after Liver Transplantation. SHILAP Revista de lepidopterología. 2020. 1–6.
11.
Tran, Thao, et al.. (2020). Brain MR Spectroscopy Markers of Encephalopathy Due to Nonalcoholic Steatohepatitis. Journal of Neuroimaging. 30(5). 697–703. 3 indexed citations
12.
Harrison, Stephen A., Zachary Goodman, Abdul Jabbar, et al.. (2019). A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis. Journal of Hepatology. 72(5). 816–827. 188 indexed citations
13.
Noureddin, Mazen, et al.. (2018). Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals. World Journal of Gastroenterology. 24(11). 1269–1277. 48 indexed citations
14.
Han, Ma Ai Thanda, Rola Saouaf, Walid S. Ayoub, et al.. (2017). Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD). Expert Review of Clinical Pharmacology. 10(4). 379–390. 33 indexed citations
15.
Tong, Myron J., et al.. (2015). Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis. Hepatology International. 9(4). 567–577. 4 indexed citations
16.
Fong, Tse–Ling, Danny Chu, Eddie C. Cheung, et al.. (2015). Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir. Digestive Diseases and Sciences. 60(11). 3465–3472. 15 indexed citations
17.
Han, Steven‐Huy B., Edward Mena, Michael Li, et al.. (2012). Adherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy. Journal of Medical Economics. 15(6). 1159–1166. 12 indexed citations
18.
Sapey, Thierry, et al.. (2005). Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center. Journal of Gastroenterology and Hepatology. 20(2). 187–192. 36 indexed citations
19.
Mena, Edward, Nir Kossovsky, Charles C. Chu, & Charles Hu. (1995). Inflammatory Intermediates Produced by Tissues Encasing Silicone Breast Prostheses. Journal of Investigative Surgery. 8(1). 31–42. 14 indexed citations
20.
Horwith, Melvin, L Krook, I. MacIntyre, et al.. (1977). Calcitonin treatment in hereditary bone dysplasia with hyperphosphatasemia: a radiographic and histologic study of bone. American Journal of Roentgenology. 129(1). 29–35. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026